Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

US Patent 11680072 · Granted Jun 20, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clock control method and electronic device thereof2025
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,2025
Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neopla2025
Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neopla2025
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alp2025
Address conversion system and address conversion method2025
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors2025
Immunoproteasome inhibitors2025
Displaying content transmitted by an external device based on detection of a con2025
Alkaline cleaning composition, cleaning method, and manufacturing method of semi2025
Bluetooth audio broadcasting system and related multi-member bluetooth device su2025
Bluetooth audio broadcasting system supporting Bluetooth low energy audio broadc2025